Boston Scientific announces agreement to acquire Vertiflex, Inc.
May 9, 2019

Clarus Therapeutics receives U.S. FDA approval of JATENZO®                                               March 27, 2019

Edwards Lifesciences Enters Into Agreement To Acquire CASMED                                           February 12, 2019

Ethicon Announces Agreement to Acquire Torax Medical, Inc.                                             February 17, 2017

Partners Group to Acquire PCI Pharma Services, A Leading Global Provider of Outsourced Pharmaceutical Services                                                                                                             June 1, 2016

Jazz Pharmaceuticals and Celator Pharmaceuticals Announce Agreement for Jazz Pharmaceuticals to Acquire Celator for $30.25 Per Share
May 31, 2016

BTG plc acquires Galil Medical, a leader in cryoablation
May 6, 2016

Celator Announces Phase 3 Trial for VYXEOS (CPX-351) in Patients With High Risk Acute Myeloid Leukemia Demonstrates Statistically Significant Improvement in Overall Survival
March 14, 2016

VERTIFLEX® Announces Two Significant Reimbursement Milestones to Expand Market Opportunity For Superion Interspinous Spacer VERTIFLEX®                                                     November 10, 2015

Celator (R) Pharmaceuticals Announces Positive Induction Response Results from Phase 3 Study of CPX-351 in Patients with High-Risk (Secondary) Acute  Myeloid Leukemia
June 24, 2015

VertiFlex(R), Inc. Announces FDA PMA Approval for the Superion(R) Interspinous Spacer
May 26, 2015

Teva Reinforces Leadership Position in CNS with Acquisition of Auspex
March 30, 2015

Boston Scientific Receives FDA Approval for Watchman (TM) Left Atrial Appendage Closure Device
March 13, 2015

Invitae Announces Pricing of Initial Public Offering of Common Stock
February 11, 2015

Auspex Pharmaceuticals Completes Enrollment in a Pivotal Clinical Trial of 809 in Tardive Dyskinesia
February 3, 2015

Auspex Announces Pricing of Follow On Offering
January 23, 2015

Auspex Announces Topline Results from Registration Trial of SD-809 for Chorea Associated with Huntington's Disease
December 16, 2014

Auspex Pharmaceuticals Receives FDA Orphan Drug Designation of SD-809 for Treatment of Huntington's Disease
November 6, 2014

Invitae Completes $120 Million Series F Financing
October 13, 2014

Pfizer Completes Acquisition of InnoPharma
September 25, 2014

PCI Announces Definitive Agreement to Acquire Penn Pharma
July 28, 2014

Pfizer to Acquire InnoPharma, Inc.
July 16, 2014

Auspex Pharmaceuticals Announces Data From Interim Analysis of ARC-HD Switch Trial Demonstrating Clinical Activity of SD-809
June 23, 2014

CASMED Receives FDA Approval for FORE-SITE ELITE in Non-Cerebral Tissue
May 7, 2014

Auspex Announces Completion of Public Offering and Exercise In Full Of Underwriters' Over-Allotment Option
February 10, 2014

Auspex Announces Pricing of Initial Public Offering
February 5, 2014